Literature DB >> 29893812

The Concern for Vancomycin Failure in the Treatment of Pediatric Staphylococcus aureus Disease.

Isaac P Thomsen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 29893812      PMCID： PMC6336910          DOI： 10.1093/cid/ciy497

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  17 in total

1.  Vancomycin: a history.

Authors:  Donald P Levine
Journal:  Clin Infect Dis       Date:  2006-01-01       Impact factor: 9.079

Review 2.  Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.

Authors:  Michael Z David; Matthew Dryden; Thomas Gottlieb; Pierre Tattevin; Ian M Gould
Journal:  Int J Antimicrob Agents       Date:  2017-06-27       Impact factor: 5.283

3.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

4.  Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis.

Authors:  Ashley L Dumont; Tyler K Nygaard; Robert L Watkins; Amanda Smith; Lina Kozhaya; Barry N Kreiswirth; Bo Shopsin; Derya Unutmaz; Jovanka M Voyich; Victor J Torres
Journal:  Mol Microbiol       Date:  2010-12-13       Impact factor: 3.501

5.  Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Ravi J Patel; Olaf Schneewind
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

6.  Selective sensitization of human neutrophils to LukGH mediated cytotoxicity by Staphylococcus aureus and IL-8.

Authors:  Philipp Janesch; Harald Rouha; Susanne Weber; Stefan Malafa; Karin Gross; Barbara Maierhofer; Adriana Badarau; Zehra C Visram; Lukas Stulik; Eszter Nagy
Journal:  J Infect       Date:  2017-02-22       Impact factor: 6.072

Review 7.  Systematic Review and Meta-Analysis of Acute Kidney Injury Associated with Concomitant Vancomycin and Piperacillin/tazobactam.

Authors:  Drayton A Hammond; Melanie N Smith; Chenghui Li; Sarah M Hayes; Katherine Lusardi; P Brandon Bookstaver
Journal:  Clin Infect Dis       Date:  2016-12-10       Impact factor: 9.079

8.  Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012.

Authors:  James Baggs; Scott K Fridkin; Lori A Pollack; Arjun Srinivasan; John A Jernigan
Journal:  JAMA Intern Med       Date:  2016-11-01       Impact factor: 21.873

9.  Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.

Authors:  Yasmin Maor; Michal Hagin; Natasha Belausov; Nathan Keller; Debbi Ben-David; Galia Rahav
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

Review 10.  A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.

Authors:  Michael T Guskey; Brian T Tsuji
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705
View more
  2 in total

Review 1.  Staphylococcus aureus infections in children.

Authors:  James E Cassat; Isaac Thomsen
Journal:  Curr Opin Infect Dis       Date:  2021-10-01       Impact factor: 4.968

2.  In Vitro Antibacterial Experiments of Qixingjian Decoction and Its Synergistic Interaction with Oxacillin against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.

Authors:  Siyuan Lv; Tingxuan Huang; Ying Lin; Xingwei Yao; Huiyong Yu; Guoxing Liu; Yue Zhang; Tong Liu; Huan Liang; Chengxiang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-16       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.